Page 2 of 2
12

2014 (3 POSTS)

Unice KM, Kerger BD, Paustenbach DJ, Finley BL, Tvermoes BE. 2014. Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure. Chem-Biol Interact 216:53–74; doi: 10.1016/j.cbi.2014.04.001. PMID: 24726710.

View Abstract

Tvermoes BE, Unice KM, Paustenbach DJ, Finley BL, Otani JM, Galbraith DA. 2014. Effects and blood concentrations of cobalt after ingestion of 1 mg/d by human volunteers for 90 d1-3. Am J Clin Nutr 99(3):632–646, doi: 10.3945/ajcn.113.071449. PMID: 24500148.

2013 (1 POST)

Kerger BD, Tvermoes BE, Unice KM, Finley BL, Paustenbach DJ, Galbraith DA. 2013. Cobalt speciation assay for human serum, Part II. Method validation in a study of human volunteers ingesting cobalt (II) chloride dietary supplement for 90 days. Toxicol Environ Chem 95(4):709–718; doi: 10.1080/02772248.2013.792559.

View Abstract

2012 (3 POSTS)

Phelka AD, Finley BL. 2012. Potential health hazards associated with exposures to asbestos-containing drywall accessory products: A state-of-the-science assessment. Crit Rev Toxicol 42(1):1–27; doi: 10.3109/10408444.2011.613067. PMID: 22044019.

View Abstract

Finley BL, Pierce JS, Paustenbach DJ, Scott LLF, Lievense L, Scott PK, Galbraith DA. 2012. Malignant pleural mesothelioma in U.S. automotive mechanics: Reported vs. expected number of cases from 1975-2007. Regul Toxicol Pharmacol 64(1):14–116; doi: 10.1016/j.yrtph.2012.05.015. PMID: 22668748.

View Abstract

Finley BL, Pierce JS, Phelka AD, Adams RE, Paustenbach DJ, Thuett KA, Barlow CA. 2012. Evaluation of tremolite asbestos exposures associated with the use of commercial products. Crit Rev Toxicol 42(2):119–146. doi: 10.3109/10408444.2011.636028. PMID: 22141364.

View Abstract

2011 (1 POST)

Pierce JS, Abelmann A, SpicerLJ, Adams RE, GlynnME, Neier K, Finley BL, Gaffney SH. 2011. Characterization of formaldehyde exposure resulting from the use of four professional hair straightening products. J Occup Environ Hyg 8(11):686–699; doi: 10.1080/15459624.2011.626259. PMID: 22035353.

View Abstract

2008 (2 POSTS)

Donovan EP, Staskal DF, Unice KM, Roberts JD, Haws LC, Finley BL, and Harris MA. 2008. Risk of gastrointestinal disease associated with exposure to pathogens in the sediments of the Lower Passaic River. Appl Environ Microbiol 74:1004-1018.

View Abstract

Staskal DF, Donovan EP, Haws LC, Roberts JD, Unice KM, Finley BL, Harris MA. Human health risks associated with exposure to pathogens in waters and sediments of the Lower Passaic River. Presented at the Society of Toxicology 47th Annual Meeting, Seattle, WA, 2008.

2007 (2 POSTS)

Haws, L.C., L.L.F. Scott, D.F. StaskalM.A. Harris, and B.L. Finley. Dioxin-like compounds in workers at a primary magnesium production facility. Dioxin 2008, Tokyo, Japan, 2007.

Staskal DF, Donovan E, Roberts J, Unice K, Finley B, Harris M. Human health risk associated with exposure to pathogen-contaminated sediments. Society of Toxicology 46th Annual Meeting, Charlotte, NC, 2007.

2006 (1 POST)

Haws LC, DeVito MJ, Birnbaum LS, Walker NJ, Scott PK, Unice KM, Harris MA, Farland WH, Finley BL, Staskal DF. An alternative method for establishing TEFs for dioxin-like compounds. Part 2. Development of an approach to quantitatively weight the underlying potency data. Dioxin 2006, Oslo, Norway, 2006.

2005 (2 POSTS)

Connor K, Harris M, Edwards M, Chu A, Clark G, Finley B. Estimating the total TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Dioxin 2005, Toronto, Canada, 2005.

Harris M, Finley B. The TCDD TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Society of Toxicology 44th Annual Meeting, New Orleans, LA, 2005.

1997 (1 POST)

Finley BL, Burton S, Panko JM, Proctor DM. 1997. A preliminary assessment of PCB risks to human and ecological health in the lower Passaic River. J Soc Environ Tox Chem 52(2):95–118.

View Abstract
Page 2 of 2
12